Retrospective Cohort Study
Copyright ©The Author(s) 2024.
World J Gastrointest Surg. Mar 27, 2024; 16(3): 689-699
Published online Mar 27, 2024. doi: 10.4240/wjgs.v16.i3.689
Figure 1
Figure 1 Flowchart of patient screening. PDAC: Pancreatic ductal adenocarcinoma; CT: Celiac trunk; CHA: Common hepatic artery; SMA: Superior mesenteric artery; PV: Portal vein; SMV: Superior mesenteric vein.
Figure 2
Figure 2 Radical dissection of lymphatic and neural tissue within the TRIANGLE area surrounded by the celiac trunk, superior mesenteric artery, and portal vein. CT: Celiac trunk; PV: Portal vein; SMA: Superior mesenteric artery.
Figure 3
Figure 3 Comparison of overall recurrence rate and local recurrence rate between pancreaticoduodenectomystandard group and pancreaticoduodenectomyTRIANGLE group. PD: Pancreaticoduodenectomy.
Figure 4
Figure 4 Long-term prognosis of pancreaticoduodenectomystandard group and pancreaticoduodenectomyTRIANGLE group. A: Disease-free survival of pancreaticoduodenectomy (PD)standard group and PDTRIANGLE group; B: Overall survival of PDstandard group and PDTRIANGLE group. PD: Pancreaticoduodenectomy; DFS: Disease-free survival; OS: Overall survival.